General Information of the Compound
Compound ID |
CP0454640
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-[4-[2-[[(2R)-2-hydroxy-2-pyridin-3-ylethyl]amino]ethyl]phenyl]-4-(5-methyl-1,2,4-oxadiazol-3-yl)benzenesulfonamide
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C24H25N5O4S
|
||||||||||||||||||
Molecular Weight |
479.562
|
||||||||||||||||||
Canonical SMILES |
Cc1nc(no1)-c1ccc(cc1)S(=O)(=O)Nc1ccc(CCNC[C@H](O)c2cccnc2)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C24H25N5O4S/c1-17-27-24(28-33-17)19-6-10-22(11-7-19)34(31,32)29-21-8-4-18(5-9-21)12-14-26-16-23(30)20-3-2-13-25-15-20/h2-11,13,15,23,26,29-30H,12,14,16H2,1H3/t23-/m0/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
ZYGLGCDPFJSPKY-QHCPKHFHSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01179, Beta-1 adrenergic receptor
Protein ID: PT01494, Beta-2 adrenergic receptor